COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine
Publication/Presentation Date
11-2022
Volume
24
Issue
6
Published In/Presented At
Oh, J., Amber-Monta, K., Sahota, P. C., Pradhan, B. K., & Koola, M. M. (2022). COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine. The primary care companion for CNS disorders, 24(6), 22cr03394. https://doi.org/10.4088/PCC.22cr03394
Disciplines
Psychiatry
PubMedID
36399386
Department(s)
Department of Psychiatry, Fellows and Residents
Document Type
Article
COinS